Motivational Interviewing to Address Suicidal Ideation: A Randomized Controlled Trial in Veterans

Suicide & Life-threatening Behavior
Peter C BrittonStephen A Maisto

Abstract

Although the months following discharge from psychiatric hospitalization are a period of acute risk for veterans, there is a dearth of empirically supported treatments tailored to veterans in acute psychiatric hospitalization. We conducted a randomized controlled trial to test the efficacy of Motivational Interviewing to Address Suicidal Ideation (MI-SI) that explored and resolved ambivalence, and a revised MI-SI (MI-SI-R) that resolved ambivalence, on suicidal ideation (SI) in hospitalized veterans who scored > 2 on the Scale for Suicidal Ideation. Participants were randomized to receive MI-SI plus treatment as usual (TAU), MI-SI-R+TAU, or TAU alone. MI-SI+TAU and MI-SI-R+TAU included two in-hospital therapy sessions and one telephone booster session. Participants completed follow-up assessments over 6 months. Participants in all groups experienced reductions in the presence and severity of SI, but there were no significant differences among the groups. For the presence of SI, results were in the hypothesized direction for both MI-SI+TAU conditions. Results are nondefinitive, but the effect size of both versions of MI-SI+TAU on the presence of SI was consistent with prior MI findings. Exploratory analyses suggest MI-SI-R may b...Continue Reading

References

Apr 1, 1979·Journal of Consulting and Clinical Psychology·A T BeckA Weissman
Apr 1, 1977·Journal of Clinical Psychology·M Kovacs, A T Beck
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Oct 1, 1981·Archives of General Psychiatry·R P Liberman, T Eckman
Jan 1, 1982·Addictive Behaviors·H A Skinner
May 12, 1993·JAMA : the Journal of the American Medical Association·R M CrumM F Folstein
Mar 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·E C Harris, B Barraclough
Feb 12, 1998·Behaviour Research and Therapy·A T BeckR A Steer
Jan 23, 1999·American Journal of Obstetrics and Gynecology·J Seguin
Jul 7, 2000·Journal of Consulting and Clinical Psychology·G K BrownJ R Grisham
Mar 29, 2002·Lancet·Kenneth F Schulz, David A Grimes
Sep 3, 2002·The British Journal of Psychiatry : the Journal of Mental Science·David OwensAllan House
Feb 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Roel VerheulWim Van Den Brink
Oct 1, 2003·Journal of Consulting and Clinical Psychology·Brian L BurkeMarisa Menchola
Oct 1, 2003·Journal of Consulting and Clinical Psychology·Paul C AmrheinLaura Fulcher
Mar 5, 2004·JAMA : the Journal of the American Medical Association·Martha L BruceGeorge S Alexopoulos
Jan 29, 2005·The American Journal of Psychiatry·Rani A DesaiRobert A Rosenheck
Feb 23, 2005·Journal of Substance Abuse Treatment·Theresa B MoyersWilliam R Miller
Jul 12, 2005·Behaviour Research and Therapy·Louisa M C van den BoschWim van den Brink
Aug 4, 2005·JAMA : the Journal of the American Medical Association·Gregory K BrownAaron T Beck
Oct 4, 2005·The American Journal of Psychiatry·Gregory K BrownAaron T Beck
Feb 8, 2006·Schizophrenia Research·Nicholas TarrierUNKNOWN SoCRATES Trial Group
Aug 25, 2007·Annual Review of Clinical Psychology·Jennifer HettemaWilliam R Miller
Nov 9, 2007·The Journal of Behavioral Health Services & Research·Mayur M DesaiRani A Desai
Nov 21, 2007·The Journal of Head Trauma Rehabilitation·John D Corrigan, Jennifer Bogner
Dec 22, 2007·Behavior Modification·Nicholas TarrierPatricia Gooding
Dec 28, 2007·Journal of Clinical Psychology·Peter C BrittonKenneth R Conner
May 6, 2008·Orphanet Journal of Rare Diseases·Shein-Chung Chow, Mark Chang
Jul 16, 2008·Archives of Neurology·Sid E O'BryantJohn A Lucas
Jul 17, 2008·Journal of Rehabilitation Research and Development·Stefanie M KeenKaren E Krinsley
Sep 18, 2008·Bulletin of the World Health Organization·Alexandra FleischmannHuong Tran Thi Thanh
Mar 20, 2009·Annual Review of Public Health·C Hendricks BrownRobert D Gibbons
Jun 17, 2009·The American Journal of Psychiatry·George S AlexopoulosUNKNOWN PROSPECT Group
Sep 11, 2009·The American Psychologist·William R Miller, Gary S Rose
Dec 9, 2009·Journal of Consulting and Clinical Psychology·Theresa B MoyersJ Scott Tonigan
Jan 28, 2010·Journal of General Internal Medicine·Elizabeth M YanoDonna L Washington
Nov 3, 2010·Archives of General Psychiatry·Mark A IlgenFrederic C Blow
Jul 4, 2012·Journal of Clinical Psychology·Peter C BrittonStephen A Maisto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.